GGrantIndex
Sort

50,496 grants matching lung cancer

Core G: Clinical and Comorbidity Research

$534,501
Mari M Kitahata · University Of Washington · P30 · FY2024 · AI

Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation of

$534,492
Melissa J Suter · Massachusetts General Hospital · R01 · FY2016 · CA

Functional role of the MUC1-C oncoprotein in non-small cell lung cancer

$534,201
Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2015 · CA

Functional role of the MUC1-C oncoprotein in non-small cell lung cancer

$534,201
Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2016 · CA

Functional role of the MUC1-C oncoprotein in non-small cell lung cancer

$534,201
Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2012 · CA

The Brooklyn Minority-Based Community Clinical Oncology Program

$534,190
William Barney Solomon · Suny Downstate Medical Center · U10 · FY2010 · CA

Identification of viral exposure signatures for early detection of liver cancer

$534,122
Limin Wang · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA

Assessing the Impact of State Preemption Laws

$534,091
Sunday Azagba · Pennsylvania State University, The · R01 · FY2021 · CA

Systemic Glucocorticoid Signaling Induced by Breast Cancer Cell Derived Extracellular Vesicles

$534,083
Shizhen Emily Wang · University Of California, San Diego · R01 · FY2025 · CA

Targeted Radiotherapy of Neoplastic Meningitis using Monoclonal Antibodies Label

$534,032
Michael Rod Zalutsky · Duke University · P01 · FY2016 · CA

Project I: Systems analysis of tumor-stroma interactions in brain metastasis

$533,949
Joan Massague · Sloan-Kettering Inst Can Research · U54 · FY2022 · CA

Chemical Methods for Ferrous Iron Dependent Drug Delivery

$533,884
Adam R Renslo · University Of California, San Francisco · R01 · FY2019 · AI

Lung Cancer Prognosis: FLT PET and DNA Hypermethylation

$533,880
Hubert J Vesselle · University Of Washington · R01 · FY2006 · CA

Biomarkers of lung cancer risk

$533,833
Paul Joseph Brennan · Baylor College Of Medicine · U19 · FY2021 · CA

A deubiquitination module controls Treg adaptation to tumor microenvironment

$533,802
Deyu Fang · Northwestern University At Chicago · R01 · FY2024 · CA

Pdcd4-Rictor Interaction in Suppression of Lung Tumorigenesis

$533,720
Hsin-Sheng Yang · University Of Kentucky · R01 · FY2025 · CA

PLURIDIRECTIONAL HIGH-ENERGY AGILE SCANNING ELECTRON RADIOTHERAPY (PHASER): EXTREMELY RAPID TREATMENT FOR EARLY LUNG CANCER

$533,649
The Leland Stanford Junior University · · FY2013 · Department of Defense

Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis

$533,624
Ramon C. Sun · University Of Florida · R01 · FY2023 · CA

Expression signatures of TB-specific memory responses within the human lung

$533,617
Richard F Silver · Case Western Reserve University · R01 · FY2016 · HL

Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation of

$533,603
Melissa J Suter · Massachusetts General Hospital · R01 · FY2015 · CA

Late Stage Lung Cancer

$533,509
Robert Figlin · Beckman Research Institute/City Of Hope · P01 · FY2011 · CA

Mechanisms of dual inhibition of TGFbeta/PD-L1 in HNSCC

$533,483
Xiao-Jing Wang · University Of Colorado Denver · R01 · FY2020 · DE

Mechanisms of dual inhibition of TGFbeta/PD-L1 in HNSCC

$533,483
Xiao-Jing Wang · University Of Colorado Denver · R01 · FY2019 · DE

Mechanisms of dual inhibition of TGFbeta/PD-L1 in HNSCC

$533,483
Xiao-Jing Wang · University Of Colorado Denver · R01 · FY2021 · DE

Project 4: Risk stratification for pulmonary nodules detected by CT imaging using plasma and imaging biomarkers

$533,455
Paul D Lampe · Fred Hutchinson Cancer Research Center · P50 · FY2019 · CA